Preetam Shah - Sep 15, 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CFO & CBO
Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Sep 15, 2022
Transactions value $
-$12,035
Form type
4
Date filed
9/19/2022, 08:28 PM
Previous filing
Apr 4, 2022
Next filing
Mar 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Options Exercise $0 +50K +42.94% $0.00 166K Sep 15, 2022 Direct F1, F2
transaction CDTX Common Stock Sale -$12K -15.6K -9.4% $0.77 151K Sep 19, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Restricted Stock Unit Options Exercise $0 -50K -100% $0.00* 0 Sep 15, 2022 Common Stock 50K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on September 15, 2022.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022.
F3 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 15, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F4 Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F5 On September 1, 2021, the Reporting Person was granted restricted stock units totaling 50,000 shares subject to vesting upon the achievement of various milestones.